{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:15Z","timestamp":1791388095040,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.exphem.2010.05.008","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T05:45:56Z","timestamp":1275457556000},"page":"896-907","source":"Crossref","is-referenced-by-count":37,"title":["H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells"],"prefix":"10.1016","volume":"38","author":[{"given":"Emir","family":"Hadzijusufovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline V.","family":"Gleixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried F.","family":"Pickl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuddow","family":"Thaiwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Yuzbasiyan-Gurkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mirkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Willmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2010.05.008_bib1","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis","volume":"108","author":"Valent","year":"1996","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.exphem.2010.05.008_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2010.05.008_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","article-title":"Diagnosis and treatment of systemic mastocytosis: state of the art","volume":"122","author":"Valent","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2010.05.008_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.exphem.2010.05.008_bib5","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.05.008_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal. Conference Report of \u201cYear 2000 Working Conference on Mastocytosis.\u201d","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2010.05.008_bib7","series-title":"World Health Organization\u00a0(WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues","first-page":"291","article-title":"Mastocytosis (mast cell disease)","author":"Valent","year":"2001"},{"key":"10.1016\/j.exphem.2010.05.008_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2010.05.008_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00062752-200401000-00009","article-title":"Clinical, genetic, and therapeutic insights into systemic mast cell disease","volume":"11","author":"Tefferi","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2010.05.008_bib10","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.05.008_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.0960-135X.2004.01369.x","article-title":"On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts","volume":"34","author":"Valent","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.exphem.2010.05.008_bib12","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","article-title":"Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation","volume":"106","author":"Gotlib","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.05.008_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.05.008_bib14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA), and evaluation of cooperative drug effects","volume":"107","author":"Gleixner","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.05.008_bib15","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.exphem.2007.06.005","article-title":"Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells","volume":"35","author":"Gleixner","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2010.05.008_bib16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3324\/haematol.11339","article-title":"Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT","volume":"92","author":"Gleixner","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2010.05.008_bib17","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","article-title":"Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2010.05.008_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.leukres.2008.09.027","article-title":"Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V","volume":"33","author":"Ustun","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2010.05.008_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mc.10118","article-title":"Molecular mechanisms of Go\/G1 cell-cycle arrest and apoptosis induced by Terfenadine in human cancer cells","volume":"37","author":"Liu","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.exphem.2010.05.008_bib20","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/carcin\/bgl021","article-title":"H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells","volume":"27","author":"Jangi","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.exphem.2010.05.008_bib21","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1023\/B:DDAS.0000043377.30075.ac","article-title":"The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines","volume":"49","author":"Rajendra","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.exphem.2010.05.008_bib22","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2005-12-028456","article-title":"The CML-related oncoprotein BCR\/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells","volume":"108","author":"Aichberger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.05.008_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2010.05.008_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated forms of c-kit","volume":"31","author":"Akin","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2010.05.008_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/ajrcmb\/3.5.413","article-title":"Establishment of two dog mastocytoma cell lines in continuous culture","volume":"3","author":"DeVinney","year":"1990","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.exphem.2010.05.008_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.imlet.2007.02.003","article-title":"Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15\/1 versus anti-IgE Omalizumab","volume":"109","author":"Mirkina","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.exphem.2010.05.008_bib27","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V73.7.1778.1778","article-title":"Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes","volume":"73","author":"Valent","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.05.008_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.vetimm.2006.11.009","article-title":"Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells","volume":"115","author":"Rebuzzi","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.exphem.2010.05.008_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1439-0264.2002.00398.x","article-title":"Morphological and biochemical aspects of apoptosis, oncosis and necrosis","volume":"31","author":"Van Cruchten","year":"2002","journal-title":"Anat Histol Embryol"},{"key":"10.1016\/j.exphem.2010.05.008_bib30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/jpet.109.152017","article-title":"Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo","volume":"329","author":"Chen","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.exphem.2010.05.008_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/mc.20165","article-title":"Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2\/M phase cell-cycle arrest and apoptosis","volume":"45","author":"Chen","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.exphem.2010.05.008_bib32","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2010.05.008_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2010.05.008_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","article-title":"Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis","volume":"113","author":"Fritsche-Polanz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2010.05.008_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","article-title":"Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts","volume":"127","author":"Feger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.exphem.2010.05.008_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1523-1747.1999.00488.x","article-title":"Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms","volume":"112","author":"Ma","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.exphem.2010.05.008_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vetimm.2009.05.007","article-title":"Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation","volume":"132","author":"Hadzijusufovic","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.exphem.2010.05.008_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.0022-202X.2004.22721.x","article-title":"Human skin mast cells express H2 and H4, but not H3 receptors","volume":"123","author":"Lippert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.exphem.2010.05.008_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/scbi.2000.0306","article-title":"H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells","volume":"10","author":"Radv\u00e1ny","year":"2000","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.exphem.2010.05.008_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/10428190009148858","article-title":"Histamine as an autocrine regulator of leukemic cell proliferation","volume":"36","author":"Malaviya","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2010.05.008_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/scbi.2000.0303","article-title":"Histamine as an autocrine growth factor: an unusual role for a widespread mediator","volume":"10","author":"Rivera","year":"2000","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.exphem.2010.05.008_bib42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1471-4906(01)02050-6","article-title":"Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation","volume":"22","author":"Falus","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2010.05.008_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00008390-200306000-00003","article-title":"Autonomous histamine metabolism in human melanoma cells","volume":"13","author":"Darvas","year":"2003","journal-title":"Melanoma Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10002043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10002043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T08:30:21Z","timestamp":1591345821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X10002043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0301472X10002043"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2010.05.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}